Medication adherence in type 2 diabetes mellitus patients: a cross-sectional study
DOI:
https://doi.org/10.32385/rpmgf.v36i2.12395Palabras clave:
Diabetes Mellitus, Type 2, Adherence, Socioeconomic factors, Depression, PortugalResumen
Objectives: To evaluate the adherence to medication in patients with type 2 Diabetes Mellitus and to assess its impact on the disease-oriented outcomes.
Type of Study: Cross-sectional.
Location: Porto, Portugal.
Population: Patients with type 2 Diabetes Mellitus from a Primary Care Setting.
Methods: A convenience sample of patients regularly attending a Primary Care Setting, from July to October 2017, answered anonymously a survey delivered by their family physician. Adherence was assessed by Treatment Adherence Measure questionnaire. Other evaluated variables were demographic and psychosocial factors and disease-oriented outcomes (weight, height, glycated hemoglobin and blood pressure).
Results: Eighty-five patients completed the study (54.1% of females) with a mean age of 61.3 years (± 13.8 years). The proportion of patients presenting good adherence to medication was 62.3% (95% CI: 51.8 - 72.9%). The lowest adherence is more common in patients with depressive symptoms (p = 0.004), history of smoking habits (p = 0.019), living alone (p = 0.009) or living without a marital partner (p = 0.039), and it is associated with higher glycated hemoglobin levels (p = 0.004).
Conclusions: Poor adherence to medication is a significant problem in the diabetic population, leading to lower glycemic control rates. The identification of its determinants allow us to design a specific intervention in primary care, both in patients’ education and in therapeutic approach, able to improve their health outcomes.
Descargas
Descargas
Publicado
Número
Sección
Licencia
Los autores otorgan a RPMGF el derecho exclusivo de publicar y distribuir en medios físicos, electrónicos, de radiodifusión u otros medios que pueda existir el contenido del manuscrito identificado en esta declaración. También otorgan a RPMGF el derecho de usar y explorar el presente manuscrito, es decir, de ceder, vender o licenciar su contenido. Esta autorización es permanente y entra en vigor desde el momento en que se envía el manuscrito, tiene la duración máxima permitida por la legislación portuguesa o internacional aplicable y tiene un alcance mundial. Los autores declaran además que esta transferencia se realiza de forma gratuita. Si la RPMGF informa a los autores que ha decidido no publicar su manuscrito, la cesión exclusiva de derechos cesa inmediatamente.
Los autores autorizan a RPMGF (oa una entidad que éste designe) a actuar en su nombre cuando considere que existe una infracción a los derechos de autor.